Compare GLBE & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLBE | MMED |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.7B |
| IPO Year | 2020 | 2025 |
| Metric | GLBE | MMED |
|---|---|---|
| Price | $38.10 | $22.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $47.08 | $22.56 |
| AVG Volume (30 Days) | 1.0M | ★ 1.9M |
| Earning Date | 05-13-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $31.78 | $15.99 |
| Revenue Next Year | $24.45 | $10.00 |
| P/E Ratio | $89.26 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $26.85 | $10.65 |
| 52 Week High | $43.99 | $24.43 |
| Indicator | GLBE | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 62.94 |
| Support Level | $35.65 | $10.68 |
| Resistance Level | $37.38 | $24.43 |
| Average True Range (ATR) | 1.30 | 1.08 |
| MACD | -0.15 | -0.12 |
| Stochastic Oscillator | 38.45 | 63.70 |
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.